Zomedica holds Q1 2026 earnings call on companion animal market

Zomedica Corp. conducted its first quarter 2026 earnings call on May 29, focusing on the companion animal veterinary technology sector.

The call featured company executives including President and CEO Larry Heaton, along with Amy Schaeffer, Tammy Pierce, Paul Tye as Vice President of International, and Mike Zuehlke as Senior VP of Finance and Corporate Controller. Participants outlined the company's positioning in daily clinical workflows for veterinarians and the market opportunity in companion animal care as a driver of recurring growth.

관련 기사

Verrica Pharmaceuticals Inc. conducted its first quarter 2026 earnings conference call on May 12.

AI에 의해 보고됨

Ceva, Inc. conducted its first quarter 2026 earnings conference call on May 11, 2026. Executives reviewed business performance and highlighted key financial measures during the event.

Central Garden & Pet Company conducted its fiscal 2026 second quarter earnings call on May 6, 2026. Executives discussed company performance during the session.

AI에 의해 보고됨

Adaptive Biotechnologies Corporation conducted its first quarter 2026 earnings conference call on May 5, 2026, at 4:30 PM EDT. Company executives, including CEO Chad Robins and CFO Kyle Piskel, presented financial results and forward-looking statements. The call is available via webcast on the company's investor relations website.

2026년 05월 26일 02시 50분

Zscaler holds third quarter 2026 earnings call

2026년 05월 13일 12시 53분

Aytu biopharma holds fiscal 2026 q3 earnings call

2026년 05월 11일 06시 05분

CI&T Inc. holds Q1 2026 earnings call

2026년 05월 08일 22시 08분

Extendicare Inc. holds Q1 2026 earnings call

2026년 05월 08일 05시 19분

Esco Technologies Inc. holds Q2 2026 earnings call

2026년 05월 07일 23시 02분

Cytek Biosciences holds first quarter 2026 earnings call

2026년 05월 07일 17시 08분

Microchip technology holds q4 2026 earnings call

2026년 05월 06일 05시 51분

PureCycle Technologies holds Q1 2026 earnings call

2026년 05월 04일 18시 31분

BioMarin holds Q1 2026 earnings call

2026년 03월 19일 05시 42분

Relmada Therapeutics holds Q4 2025 earnings conference call

 

 

 

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부